Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial

https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(24)00048-5/fulltext?dgcid=hubspot_update_feature_updatealerts_lanhl&utm_campaign=update-lanhl&utm_medium=email&_hsenc=p2ANqtz-8e7A73BI9wk9x_fEfRZUfXzwPkhkvmltRuXeLh40zC4LbSZreOJ-PLKLMgIkZjH4cvzKlieV5WSLYZtMM5oEwsWJP3Dg&_hsmi=310802778&utm_content=310424176&utm_source=hs_email